Science used to reward the lone genius—the first author who “drove the project,” the PI whose name defined a field. But the problems we face today—metabolic disease, obesity, GPCR signaling complexity—are too layered, too multidimensional, too systemic for single-discipline solutions. As Hodson put it, the work he leads now would be impossible without partnerships. Whether it's human genetics, imaging platforms, peptide chemistry, or neural metabolic mapping—every piece re

Burning Cash Isn’t the Problem. Burning Alignment Is. Every biotech founder fears the day the cash runs out. You track the burn rate. You watch the runway shrink. You delay hires. You negotiate term sheets from a place of panic. But here’s what most founders miss. 👉 Cash isn’t your biggest problem. Misalignment is. Not the obvious kind either. We’re not talking about personality clashes or investor drama. 👉 We’re talking about the type of quiet misalignment that appears to